Shares of Ampliphi Biosciences Corp (NYSEAMERICAN:APHB - Get Free Report) were down 4.6% during mid-day trading on Monday . The company traded as low as $1.94 and last traded at $1.99. Approximately 4,756 shares changed hands during trading, a decline of 99% from the average daily volume of 842,200 shares. The stock had previously closed at $2.08.
Ampliphi Biosciences Stock Down 1.9 %
The business has a 50-day simple moving average of $2.03.
Ampliphi Biosciences Company Profile
(
Get Free Report)
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Read More
Before you consider Ampliphi Biosciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ampliphi Biosciences wasn't on the list.
While Ampliphi Biosciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
